Fundraising Fox

Genecentric Therapeutics

Durham, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

CT
CLAY THORPDirector
MM
MICHAEL MILBURNExecutive Officer, Director
AL
ARNOLD LEVINEDirector
CP
CHARLES PEROUDirector
PR
Prasanth ReddyDirector
DH
Don HardisonDirector
DN
David Neil HayesExecutive Officer, Director
ML
Myla Lai-GoldmanDirector

Investors · 1

Hatteras Venture PartnersResearch Triangle · $500K – $4Mvia Myla Lai-Goldman · board

Reported raises · per SEC filings

Form D private placements
▶$2MraisedJun 2025 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • CLAY THORPDirector
  • MICHAEL MILBURNExecutive Officer, Director
  • ARNOLD LEVINEDirector
  • CHARLES PEROUDirector
  • Prasanth ReddyDirector
  • MYLA LAI-GOLDMANDirector
  • Don HardisonDirector
Offering amount
$5M
Amount sold
$2M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedSep 2022 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • ARNOLD LEVINEDirector
  • CLAY THORPDirector
  • CHARLES PEROUDirector
  • MYLA LAI-GOLDMANDirector
  • ELLEN LUBMANDirector
  • MICHAEL MILBURNExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$2.5M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedOct 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ellen LubmanDirector
  • Michael V. MilburnExecutive Officer, Director
  • Perou CharlesExecutive Officer, Director
  • Clay ThorpDirector
  • Myla Lai-GoldmanExecutive Officer, Director
  • Arnold LevineDirector
Offering amount
$7.5M
Amount sold
$4.5M
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.2MraisedJan 2021 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles PerouExecutive Officer, Director
  • Arnold LevineDirector
  • Clay ThorpDirector
  • Michael MilburnExecutive Officer, Director
  • Myla Lai-GoldmanExecutive Officer, Director
  • Ellen LubmanDirector
Offering amount
$1.2M
Amount sold
$1.2M
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6.1MraisedJan 2017 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Myla Lai-GoldmanExecutive Officer, Director
  • Clay ThorpDirector
  • Arnold LevineDirector
  • David Neil HayesExecutive Officer, Director
  • Charles PerouDirector
Offering amount
$8.6M
Amount sold
$6.1M
First sale
Dec 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.